RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Ciprofloxacin의 약물사용 평가

        연은숙,박지원,김수자,장혜경,김옥녀 한국병원약사회 1999 병원약사회지 Vol.16 No.1

        Ciprofloxacin is one of synthetic fluoroquinolone antibacterial agents which has great bactericidal activity against Gram negative aerobic organisms (especially, Enterobacteriaceae and Pseudomonas aeruginosa) and Gram positive bacteria (including Penicillinase-producing and Methicillin-sensitive Staphylococcus aureus). However, the appearance of ciprofloxacin resistant to many different microorganisms limits the use of ciprofloxacin for patients who are really needed it. This sudy was performed to analyzed the appropriateness for ciprofloxacin use in St. Mary's Hospital setting. Forty-one charts of patients who used ciprofloxacin (Ⅳ) (M/F 24/17, Jan.-Aug. of 1998) underwent drug utilization evaluation (DUE). The criterias of DUE used in this study were based on the standards by the American Society of Hospital Pharmacy which modified to be appropriate in our hospital setting : 1) Justification of drug use, 2) Critical & process indications, 3) Complications, 4) Outcome measures. Justification of use showed high appropriate rate (87.8%). Most of the critical & process indications also showed high appropriate rates (82.9 thru 97.5%) except C&S test during ciprofloxacin use (60.9%). Complications in ciprofloxacin use were usually minor symptoms such as pruritis (2.4%) and GI problems (39.0%). Also these study datas demonstrated other factors such as drug-drug interactions and co-disease could influence the complications. In case of outcome measures, the total therapeutic response showed high rate (95.1%). Only two patients (4.8%) had no response to ciprofloxacin at all. This study shows DUE analyzed for the appropriateness and problems of ciprofloxacin use. Therefore, DUE to a specific drug can apply to improve the efficacy of drug use and quality of medical service.

      • KCI등재

        오구멘틴^(R)시럽과 메피롤^(R)시럽 혼합액의 안전성 평가

        방현경,연은숙,강진숙,최귀령 한국병원약사회 2003 병원약사회지 Vol.20 No.2

        A study was carried out using HPLC to determine the chemical stability of Augmentin^(R) oral suspension (Amoxicillin and Potassium Clavulanate) and Mephirol^(R) syrup (Sobrerol and S-Carboxylmethycysteine) mixture, stored at 2~8℃ over a period of 7days. Augmentin^(R) suspension is reported to be stable for at least 7days in a refrigerator. Our main objective was to study its stability in Augmentin^(R) suspension and Mephirol^(R) syrup mixture. During the study period, amoxicillin component was found to be more stable than the clavulanate. But in a tendency, there were little difference between the Augementin^(R) suspension and the mixture. An increase in the pH of the samples was also observed as an increase in Mephirol^(R) syrup ratio. Despite the pH increase, no additional HPLC peaks were noted. On the basis these results, it is suggested that likewise the Augmentin^(R) suspension. Augmentin^(R) suspension and Mephirol^(R) syrup mixture is stable for 7days in a refrigerator.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼